Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Therapeutic strategies for autism: targeting three levels of the central dogma of molecular biology Translational Psychiatry Autism vs. "Autistic Like" Traits: What's the Difference? Hope for HIE Hypoxic Ischemic Encephalopathy Dihexa Peptide Therapy in Jupiter Cognitive Enhancement AlluraMD Inflammation may trigger autism, but healing requires both calming the immune system and rebuilding strength. Peptides that enhance brain derived and nerve growth factors can help accelerate neurological recovery and improve outcomes in